Ads
related to: lenalidomide revlimid- Dosing Information
Learn More Today
See Dosing & Administration Info.
- Ph+ CML Video
Watch a Video and Get More
Information on CML
- Pediatric CML Patients
Learn About a Treatment Option
For Children with Ph+ CML in CP
- Sign Up For Support
Get Informative Support
Information. Sign Up Here
- Dosing Information
Search results
Pfizer's (PFE) Adcetris Meets Survival Goal in Lymphoma Study
Zacks via Yahoo Finance· 3 months agoPfizer PFE announced positive overall survival data from a phase III study of Adcetris regimen in...
Legend (LEGN) Up 4% on sNDA Submission for Carvykti Expanded Use
Zacks via Yahoo Finance· 12 months agoLegend (LEGN) announces regulatory submission for expanded use of Carvykti to include adult patients...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 8 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
Zacks via Yahoo Finance· 2 months agoJohnson & Johnson JNJ announced that an FDA committee has unanimously recommended expanded use of...
Dr. Reddy's (RDY) Earnings & Revenues Trump Estimates in Q2
Zacks via Yahoo Finance· 2 years agoDr. Reddy's Laboratories Limited RDY reported second-quarter fiscal 2023 earnings of 82 cents per...
Viatris (VTRS) Down 1.5% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Viatris (VTRS). Shares have lost about 1.5%...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer stock is lingering just above its 50-day line after the company beat first-quarter sales...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
MorphoSys AG (NASDAQ:MOR) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoMorphoSys AG (NASDAQ:MOR) Q4 2022 Earnings Call Transcript March 16, 2023 Julia Neugebauer: Ladies...
Ad
related to: lenalidomide revlimid